Unicycive Therapeutics (UNCY) Inventory Average (2026)
Unicycive Therapeutics posted quarterly Inventory Average of $6.9 million for Q1 2026.
Unicycive Therapeutics (UNCY) has 1 years of Inventory Average data on file, last reported at $6.9 million in Q1 2026.
- For the quarter ending Q1 2026, Inventory Average changed N/A year-over-year to $6.9 million; the trailing twelve-month figure through Mar 2026 stood at $6.9 million (changed N/A YoY), and the FY2025 full-year result was $4.9 million, changed N/A from the prior year.
- Inventory Average for Q1 2026 stood at $6.9 million.
- Across five years, Inventory Average topped out at $6.9 million in Q1 2026 and bottomed at $6.9 million in Q1 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 30.59 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.73 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 3.15 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 83.37 Mn |
| 10 | Unicycive Therapeutics | 181.94 Mn | 127.36 Mn | - | 6.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.94 Mn |